Cargando…

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars

OBJECTIVES: To investigate the knowledge and beliefs of Australian patients with inflammatory arthritis regarding biologic/targeted synthetic DMARDs (b/tsDMARDs) and biosimilars and their sources of information. METHODS: Participants enrolled in the Australian Rheumatology Association Database (ARAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinlivan, Alannah, Lester, Susan, Barrett, Claire, Whittle, Samuel, Rowett, Debra, Black, Rachel, Chand, Vibhasha, Marine, Franca, March, Lyn, Sinnathurai, Premarani, Buchbinder, Rachelle, Hill, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682816/ https://www.ncbi.nlm.nih.gov/pubmed/36424984 http://dx.doi.org/10.1093/rap/rkac099

Ejemplares similares

Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis
por: Lyon, Andrea, et al.
Publicado: (2023)

Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study
por: Sinnathurai, Premarani, et al.
Publicado: (2018)

Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions
por: Khoo, Thomas, et al.
Publicado: (2022)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
por: Lee, Joshua L., et al.
Publicado: (2018)

Mortality estimates and excess mortality in rheumatoid arthritis
por: Black, Rachel J, et al.
Publicado: (2023)

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
por: Black, Rachel J., et al.
Publicado: (2017)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
por: Pisaniello, Huai Leng, et al.
Publicado: (2023)

Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
por: Fletcher, Ashley, et al.
Publicado: (2020)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Staples, Margaret P., et al.
Publicado: (2019)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Buchbinder, Rachelle, et al.
Publicado: (2015)

Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
por: Fletcher, Ashley, et al.
Publicado: (2022)

Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database
por: Oldroyd, John, et al.
Publicado: (2009)

Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis
por: Tiller, Georgina, et al.
Publicado: (2022)

Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database
por: Briggs, Andrew M., et al.
Publicado: (2009)

Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees
por: Tsakas, James J., et al.
Publicado: (2022)

Improving the quality use of highly specialised drugs
por: Hill, Catherine L, et al.
Publicado: (2021)

General Practitioner Management of Shoulder Pain in Comparison with Rheumatologist Expectation of Care and Best Evidence: An Australian National Survey
por: Buchbinder, Rachelle, et al.
Publicado: (2013)

Investigating Subjective Experience and the Influence of Weather Among Individuals With Fibromyalgia: A Content Analysis of Twitter
por: Delir Haghighi, Pari, et al.
Publicado: (2017)

Patient attitudes and understanding about biosimilars: an international cross-sectional survey
por: Jacobs, Ira, et al.
Publicado: (2016)

Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017
por: Wu, Aimin, et al.
Publicado: (2020)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

Spinal Cord Stimulators: An Analysis of the Adverse Events Reported to the Australian Therapeutic Goods Administration
por: Jones, Caitlin M. P., et al.
Publicado: (2022)

Evaluation of Physicians’ Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated with Their Prescribing
por: Karateev, Dmitry, et al.
Publicado: (2019)

Health literacy in a population-based sample of Australian women: a cross-sectional profile of the Geelong Osteoporosis Study
por: Hosking, Sarah M., et al.
Publicado: (2018)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Knowledge, Attitude, and Practice Towards Biosimilars and Interchangeable Products: A Prescriptive Insight by the Pharmacists
por: Shakeel, Sadia, et al.
Publicado: (2020)

An online survey among US patients with immune-mediated conditions: Attitudes about biosimilars
por: Gibofsky, Allan, et al.
Publicado: (2023)

Interoceptive hunger, eating attitudes and beliefs
por: Stevenson, Richard J., et al.
Publicado: (2023)

Biosimilars in dermatology
por: Mazur, Małgorzata, et al.
Publicado: (2015)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
por: Uifălean, Alina, et al.
Publicado: (2018)

A realist synthesis of pharmacist-conducted medication reviews in primary care after leaving hospital: what works for whom and why?
por: Luetsch, Karen, et al.
Publicado: (2021)

Patterns of Welfare Attitudes in the Australian Population
por: Schofield, Timothy P., et al.
Publicado: (2015)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
por: Poon, Samantha Yun-Kai, et al.
Publicado: (2021)

Gynaecological Malignancies Among a Representative Population of Batticaloa, Sri Lanka
por: Thirukumar, Markandu, et al.
Publicado: (2021)

Patterns of care for people presenting to Australian general practice with musculoskeletal complaints based on routinely collected data: protocol for an observational cohort study using the Population Level Analysis and Reporting (POLAR) database
por: Haas, Romi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gmcgsh2d4819lvupb2qtl3ou0q